Results 181 to 190 of about 7,190,509 (398)

PARP inhibitors elicit distinct transcriptional programs in homologous recombination competent castration‐resistant prostate cancer

open access: yesMolecular Oncology, EarlyView.
PARP inhibitors are used to treat a small subset of prostate cancer patients. These studies reveal that PARP1 activity and expression are different between European American and African American prostate cancer tissue samples. Additionally, different PARP inhibitors cause unique and overlapping transcriptional changes, notably, p53 pathway upregulation.
Moriah L. Cunningham   +21 more
wiley   +1 more source

Analyzing Commute Mode Choice Using the LCNL Model in the Post-COVID-19 Era: Evidence from China. [PDF]

open access: yesInt J Environ Res Public Health, 2022
Luan S, Yang Q, Jiang Z, Zhou H, Meng F.
europepmc   +1 more source

Business Takeover or New Venture? Individual and Environmental Determinants from a Cross-Country Study [PDF]

open access: yes
Whereas the determinants of entrepreneurial choice have been thoroughly analyzed in the literature, little is known about the preferred mode of entry into entrepreneurship, such as taking over an existing business or starting a new venture. Using a large
Block, J.H.   +3 more
core   +1 more source

Characterizing the salivary RNA landscape to identify potential diagnostic, prognostic, and follow‐up biomarkers for breast cancer

open access: yesMolecular Oncology, EarlyView.
This study explores salivary RNA for breast cancer (BC) diagnosis, prognosis, and follow‐up. High‐throughput RNA sequencing identified distinct salivary RNA signatures, including novel transcripts, that differentiate BC from healthy controls, characterize histological and molecular subtypes, and indicate lymph node involvement.
Nicholas Rajan   +9 more
wiley   +1 more source

The Comparison of Mode Choice Sensitivity to the Reduction of Travel Time and Cost in Multimodal Trip [PDF]

open access: hybrid, 2013
Mohammad Reza Ganji   +4 more
openalex   +1 more source

Bridging the gap: Multi‐stakeholder perspectives of molecular diagnostics in oncology

open access: yesMolecular Oncology, EarlyView.
Although molecular diagnostics is transforming cancer care, implementing novel technologies remains challenging. This study identifies unmet needs and technology requirements through a two‐step stakeholder involvement. Liquid biopsies for monitoring applications and predictive biomarker testing emerge as key unmet needs. Technology requirements vary by
Jorine Arnouts   +8 more
wiley   +1 more source

Factors influencing women’s choice of mode of delivery in rural Bangalore, India

open access: hybrid, 2019
Rajiv K. Saxena   +2 more
openalex   +1 more source

Home - About - Disclaimer - Privacy